We are live on ! Find out more
Bank of New York Mellon

Bank of New York Mellon Portfolio holdings

AUM $609B
1-Year Est. Return 40.19%
 

Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.

This Fund
S&P 500
This Quarter Est. Return
+10.46%
1 Year Est. Return
+40.19%
3 Year Est. Return
+118.86%
5 Year Est. Return
+156%
10 Year Est. Return
+606.23%
AUM
$438B
AUM Growth
+$25.1B
Cap. Flow
-$8.15B
Cap. Flow %
-1.86%
Top 10 Hldgs %
17.51%
Holding
4,666
New
116
Increased
1,932
Reduced
2,096
Closed
202

Top Sells

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$612M
2
AAPL icon
Apple
AAPL
+$402M
3
HUBB icon
Hubbell
HUBB
+$281M
4
ADP icon
Automatic Data Processing
ADP
+$246M
5
ECL icon
Ecolab
ECL
+$244M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 15.04%
3 Financials 12.69%
4 Industrials 9.18%
5 Consumer Discretionary 8.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POL
4076
DELISTED
Polished.com Inc.
POL
$43.1K ﹤0.01%
1,492
-5
-0.3% -$150
ASXC
4077
DELISTED
Asensus Surgical, Inc.
ASXC
$43.1K ﹤0.01%
124,169
CRIS icon
4078
Curis
CRIS
$3.91M
$43K ﹤0.01%
196
LUMO
4079
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$42.8K ﹤0.01%
11,858
DAKT icon
4080
Daktronics
DAKT
$988M
$41.8K ﹤0.01%
14,813
-26,403
-64% -$81.2K
PVLA
4081
Palvella Therapeutics
PVLA
$2.26B
$41.5K ﹤0.01%
499
CTXR icon
4082
Citius Pharmaceuticals
CTXR
$20.1M
$41.5K ﹤0.01%
2,101
PXLW icon
4083
Pixelworks
PXLW
$45.7M
$41.5K ﹤0.01%
1,954
-1
-0.1% -$18
AKBA icon
4084
Akebia Therapeutics
AKBA
$241M
$41.4K ﹤0.01%
71,836
FATH
4085
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$41.1K ﹤0.01%
1,558
EMAN
4086
DELISTED
eMagin Corporation
EMAN
$40.4K ﹤0.01%
47,473
+17,970
+61% +$14.8K
RLX icon
4087
RLX Technology
RLX
$2.44B
$40.3K ﹤0.01%
17,525
-383,258
-96% -$680K
AKA icon
4088
a.k.a. Brands
AKA
$116M
$40.3K ﹤0.01%
2,642
-24
-0.9% -$478
CIG icon
4089
CEMIG Preferred Shares
CIG
$5.58B
$40.1K ﹤0.01%
+25,666
New +$41.3K
LTRPA
4090
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$39.5K ﹤0.01%
59,006
-161
-0.3% -$151
HRTG icon
4091
Heritage Insurance Holdings
HRTG
$989M
$38.8K ﹤0.01%
21,552
-54,036
-71% -$89.1K
ORN icon
4092
Orion Group Holdings
ORN
$392M
$38.4K ﹤0.01%
16,155
AQMS icon
4093
Aqua Metals
AQMS
$10.1M
$38.3K ﹤0.01%
153
IMUX icon
4094
Immunic
IMUX
$226M
$37.9K ﹤0.01%
2,704
ENZ
4095
DELISTED
Enzo Biochem, Inc.
ENZ
$37.5K ﹤0.01%
26,217
-61,064
-70% -$119K
KRMD icon
4096
KORU Medical Systems
KRMD
$154M
$37K ﹤0.01%
10,356
DTIL icon
4097
Precision BioSciences
DTIL
$201M
$36.9K ﹤0.01%
1,033
-2
-0.2% -$79
FGH
4098
DELISTED
FG Group Holdings Inc.
FGH
$36.8K ﹤0.01%
14,062
GEG icon
4099
Great Elm Group
GEG
$67.4M
$36.8K ﹤0.01%
18,238
CDZI icon
4100
Cadiz
CDZI
$295M
$36.1K ﹤0.01%
14,450

Similar funds

Bank of New York Mellon's Q4 2022 Portfolio in Review

As of Q4 2022, Bank of New York Mellon held 4,666 positions worth $438B, up 6.1% from $413B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Bank of New York Mellon's Q4 2022 filing shows 116 new, 1,932 increased, 2,096 reduced and 202 closed positions. Its largest new stake was Rentokil: 961,656 shares worth $29.6M. The largest sale was Colgate-Palmolive, an estimated $612M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Bank of New York Mellon's largest Q4 2022 buy was Rentokil: 961,656 shares worth $29.6M.
  • Bank of New York Mellon added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $464M increase.
  • Bank of New York Mellon's biggest Q4 2022 reduction was Colgate-Palmolive, cutting an estimated $612M.
  • Bank of New York Mellon fully exited Twitter, Inc. in Q4 2022, selling an estimated $223M.
  • Bank of New York Mellon's ten largest holdings make up 18% of its $438B portfolio in Q4 2022.
  • Bank of New York Mellon opened 116 new positions and closed 202 in Q4 2022.
  • Bank of New York Mellon's portfolio value rose 6.1% quarter-over-quarter to $438B.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.